Recurrent SARS-CoV-2 infections and their potential risk to public health - a systematic review.
<h4<Objective</h4<To inform quarantine and contact-tracing policies concerning re-positive cases-cases testing positive among those recovered.<h4<Materials and methods</h4<We systematically reviewed and appraised relevant literature from PubMed and Embase for the extent of re-positive cases and their epidemiological characteristics.<h4<Results</h4<In 90 case reports/series, a total of 276 re-positive cases were found. Among confirmed reinfections, 50% occurred within 90 days from recovery. Four reports related onward transmission. In thirty-five observational studies, rate of re-positives ranged from zero to 50% with no onward transmissions reported. In eight reviews, pooled recurrence rate ranged from 12% to 17.7%. Probability of re-positive increased with several factors.<h4<Conclusion</h4<Recurrence of a positive SARS-CoV-2 test is commonly reported within the first weeks following recovery from a first infection..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
PLoS ONE - 16(2021), 12, p e0261221 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Seth Kofi Abrokwa [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
---|
doi: |
10.1371/journal.pone.0261221 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ074095048 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ074095048 | ||
003 | DE-627 | ||
005 | 20230309122548.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1371/journal.pone.0261221 |2 doi | |
035 | |a (DE-627)DOAJ074095048 | ||
035 | |a (DE-599)DOAJ18f5b966840c4dbdbb9a8785bd4668ac | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Seth Kofi Abrokwa |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recurrent SARS-CoV-2 infections and their potential risk to public health - a systematic review. |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a <h4<Objective</h4<To inform quarantine and contact-tracing policies concerning re-positive cases-cases testing positive among those recovered.<h4<Materials and methods</h4<We systematically reviewed and appraised relevant literature from PubMed and Embase for the extent of re-positive cases and their epidemiological characteristics.<h4<Results</h4<In 90 case reports/series, a total of 276 re-positive cases were found. Among confirmed reinfections, 50% occurred within 90 days from recovery. Four reports related onward transmission. In thirty-five observational studies, rate of re-positives ranged from zero to 50% with no onward transmissions reported. In eight reviews, pooled recurrence rate ranged from 12% to 17.7%. Probability of re-positive increased with several factors.<h4<Conclusion</h4<Recurrence of a positive SARS-CoV-2 test is commonly reported within the first weeks following recovery from a first infection. | ||
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
653 | 0 | |a Science | |
653 | 0 | |a Q | |
700 | 0 | |a Sophie Alice Müller |e verfasserin |4 aut | |
700 | 0 | |a Alba Méndez-Brito |e verfasserin |4 aut | |
700 | 0 | |a Johanna Hanefeld |e verfasserin |4 aut | |
700 | 0 | |a Charbel El Bcheraoui |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t PLoS ONE |d Public Library of Science (PLoS), 2007 |g 16(2021), 12, p e0261221 |w (DE-627)DOAJ000113018 |x 19326203 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2021 |g number:12, p e0261221 |
856 | 4 | 0 | |u https://doi.org/10.1371/journal.pone.0261221 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/18f5b966840c4dbdbb9a8785bd4668ac |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.1371/journal.pone.0261221 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1932-6203 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 16 |j 2021 |e 12, p e0261221 |